Colon disease targets and uses thereof
AssigneeCelera Corporation
InventorsBruno DOMON, Aiqun LI, Tao HE, Ian MCCAFFREY
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for diagnosing and detecting diseases associated with colon. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in colon diseases (CCAT) and antibodies binds to CCAT. The present invention provides that CCAT is used as targets for screening agents that modulates the CCAT activities. Further the present invention provides methods for treating diseases associated with colon.
Claims20
An isolated protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:1-683 and 1332-1501.
An isolated nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of:
- a) SEQ ID NOS:684-1331;
- b) nucleotide sequences that encode a protein comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:1-683 and 1332-1501;
- and
- c) nucleotide sequences that are completely complementary to the nucleotide sequences of a) or b).
A method of diagnosing, prognosing, or determining risk of colon cancer in a subject, the method comprising detecting at least one molecule in a sample, wherein the presence or abundance of the molecule is indicative of colon cancer, and wherein the molecule is selected from the group consisting of:
- a) proteins comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:1-683 and 1332-1501;
- b) antibodies that selectively bind to the protein of a);
- c) nucleic acid molecules comprising a nucleotide sequence selected from the group consisting of SEQ ID NOS:684-1331 and nucleotide sequences that encode the protein of a);
- and
- d) nucleic acid molecules comprising a nucleotide sequence that is completely complementary to the nucleic acid molecule of c).
Dependencies are inferred from the claim text.